Moonlake TX Immunotherapeutics
https://moonlaketx.com/
We apply stellar science, sponsoring innovative research work and clinical trials globally, to target inflammatory diseases with a major unmet need where Sonelokimab has the potential to transform …
Sonelokimab shows long-term efficacy for hidradenitis suppurativa
https://www.healio.com/news/dermatology/20260624/high-longterm-efficacy-with-sonelokimab-for-hidradenitis-suppurativa-topline-data
Jun 24, 2026 · More than 33% of adults who received sonelokimab achieved complete HS clearance with no increase in draining tunnels by 1 year. New interim data showed teens had a greater …
MoonLake Immunotherapeutics reports on week 16 results of the …
https://ir.moonlaketx.com/news-releases/news-release-details/moonlake-immunotherapeutics-reports-week-16-results-vela-phase-3
Sep 28, 2025 · For adults with HS, sonelokimab is being assessed in the Phase 3 trials, VELA-1 and VELA-2, following the successful outcome of MoonLake’s end-of-Phase 2 interactions with the FDA …
MoonLake Immunotherapeutics Aligns with FDA—Label for …
https://marketchameleon.com/articles/b/2026/5/11/moonlake-immunotherapeutics-fda-sonelokimab-hs-label-clinical-standards
May 11, 2026 · MoonLake Immunotherapeutics has reached a pivotal agreement with the FDA on its Biologics License Application for sonelokimab in hidradenitis suppurativa (HS), setting the stage for a …
MoonLake Immunotherapeutics (MLTX) gains FDA backing on HS …
https://www.stocktitan.net/news/MLTX/moon-lake-immunotherapeutics-announces-positive-outcome-from-type-b-rs5fp7nl4eqi.html
Jan 8, 2026 · The FDA indicated that MoonLake may establish substantial evidence of effectiveness (SEE) without additional clinical trials in HS, with an application consisting of data from its existing …
MoonLake Immunotherapeutics Announces New Data from Clinical Trials …
https://www.marketscreener.com/news/moonlake-immunotherapeutics-announces-new-data-from-clinical-trials-of-its-nanobody-sonelokimab-ce7d5fdbdc8df625
Nov 5, 2025 · In an interim analysis of long-term data from MoonLake's Phase 3 clinical trials in adult patients with HS, the VELA-1 and VELA-2 trials, SLK demonstrates continuous clinical improvement …
MoonLake (MLTX)’s Sonelokimab Crushes Phase 3 Goals With 35
https://biotechhealthx.com/biotech-news/moonlake-mltxs-sonelokimab-crushes-phase-3-goals-with-35-response-rate-in-hs/
Sep 29, 2025 · Sonelokimab is being studied across a broad portfolio of clinical programs, including the Phase 3 VELA trials in hidradenitis suppurativa, which use the rigorous HiSCR75 endpoint to …
MoonLake Immunotherapeutics (MLTX) Stock Price, Quote, News
https://seekingalpha.com/symbol/MLTX
A high-level overview of MoonLake Immunotherapeutics (MLTX) stock. View (MLTX) real-time stock price, chart, news, analysis, analyst reviews and more.
How MoonLake’s Phase 3 Sonelokimab HiSCR75 Data in HS Could …
https://www.sahmcapital.com/news/content/how-moonlakes-phase-3-sonelokimab-hiscr75-data-in-hs-could-shape-moonlake-immunotherapeutics-mltx-investors-2026-04-07
Apr 7, 2026 · MoonLake Immunotherapeutics recently reported long-term Week 40 Phase 3 VELA-1 and VELA-2 data for sonelokimab in moderate-to-severe hidradenitis suppurativa, showing strong efficacy …
MoonLake Immunotherapeutics: Sonelokimab's Comeback Story in ...
https://www.kavout.com/market-lens/moonlake-immunotherapeutics-sonelokimab-s-comeback-story-in-hidradenitis-suppurativa
After a tumultuous period marked by a significant share price decline following initial Phase 3 VELA-2 trial results in late 2025, the company has now unveiled robust 52-week data for its lead asset, …
Learn what is caching and how to use it effectively with proven strategies. Explore cache-aside, write-through, and invalidation techniques to boost performance.
Explore the history of the semiconductor industry and how does it work. Learn chip design, fabrication, and the global impact of this vital technology. Discover more.
Learn how to design a scalable system architecture with a step-by-step framework. Master scaling principles, microservices, and database strategies for resilient systems.
Learn what system design is and why it is important for building scalable, reliable software. Discover key principles and how to design systems that last.
Analysis of EIC Tech Report 2026: 25 early deep-tech signals to strengthen Europe. Bio-inspired AI, quantum communications, biomineralization, and surgical robotics. Who wins and who loses? Read the full review.
Learn how to answer system design interview questions with a proven 5-step framework. Master scalability, trade-offs, and ace your next tech interview. Start now.
Learn what is the difference between vpn and proxy, from encryption to scope. Discover which tool fits your privacy needs with our expert comparison.
Learn how Netflix scales its streaming infrastructure with AWS, Open Connect CDN, and chaos engineering. Discover the tech behind 270M subscribers and sub-100ms latency.
Learn how to choose a database for your system with this evidence-based framework. Compare SQL, NoSQL, graph, and time-series databases to make the right decision.
Learn how does biotechnology use genetic engineering with CRISPR, gene therapy, and more. Explore breakthroughs in medicine, agriculture, and the future of DNA editing.